beinaglutide   Click here for help

GtoPdb Ligand ID: 12863

Synonyms: Feisumei®
Approved drug
beinaglutide is an approved drug (China NMPA (2023))
Compound class: Peptide
Comment: Beinaglutide is a glucagon-like peptide-1 (GLP-1) analogue [2-3]. To our knowledge the peptide sequence and/or any anti-proteolytic modifications in beinaglutide have not been disclosed.
No information available.
Summary of Clinical Use Click here for help
Beinaglutide was approved by the China National Medical Products Administration (NMPA) in July 2023, as a weight loss drug.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT05005741 The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity. Phase 4 Interventional Second Xiangya Hospital of Central South University
NCT03829891 Study for Beinaglutide Versus Glargine Therapy in Glycemic Variability of Type 2 Diabetes Mellitus N/A Interventional Xijing Hospital
NCT03593668 Effect and Safety of Benaglutide or Metformin in Patients With Simple Obesity Who Have Inadequate Weight Control Phase 4 Interventional The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 1